nodes	percent_of_prediction	percent_of_DWPC	metapath
Nelfinavir—ABCG2—Tamoxifen—pancreatic cancer	0.0413	0.0503	CbGbCtD
Nelfinavir—SLCO1B1—Irinotecan—pancreatic cancer	0.04	0.0486	CbGbCtD
Nelfinavir—ABCG2—Erlotinib—pancreatic cancer	0.0352	0.0427	CbGbCtD
Nelfinavir—ABCG2—Irinotecan—pancreatic cancer	0.0317	0.0386	CbGbCtD
Nelfinavir—CYP3A7—Tamoxifen—pancreatic cancer	0.0305	0.0371	CbGbCtD
Nelfinavir—CYP3A7-CYP3A51P—Tamoxifen—pancreatic cancer	0.0305	0.0371	CbGbCtD
Nelfinavir—ABCG2—Fluorouracil—pancreatic cancer	0.0305	0.037	CbGbCtD
Nelfinavir—CYP2B6—Tamoxifen—pancreatic cancer	0.0291	0.0353	CbGbCtD
Nelfinavir—CYP3A7-CYP3A51P—Irinotecan—pancreatic cancer	0.0234	0.0285	CbGbCtD
Nelfinavir—CYP3A7—Irinotecan—pancreatic cancer	0.0234	0.0285	CbGbCtD
Nelfinavir—ABCG2—Docetaxel—pancreatic cancer	0.0233	0.0283	CbGbCtD
Nelfinavir—ABCG2—Sunitinib—pancreatic cancer	0.0232	0.0281	CbGbCtD
Nelfinavir—CYP3A5—Tamoxifen—pancreatic cancer	0.0229	0.0278	CbGbCtD
Nelfinavir—CYP2B6—Irinotecan—pancreatic cancer	0.0223	0.0271	CbGbCtD
Nelfinavir—CYP1A2—Dacarbazine—pancreatic cancer	0.0214	0.026	CbGbCtD
Nelfinavir—CYP3A5—Erlotinib—pancreatic cancer	0.0195	0.0237	CbGbCtD
Nelfinavir—CYP2C19—Tamoxifen—pancreatic cancer	0.0185	0.0225	CbGbCtD
Nelfinavir—CYP3A5—Irinotecan—pancreatic cancer	0.0176	0.0214	CbGbCtD
Nelfinavir—ABCG2—Doxorubicin—pancreatic cancer	0.0173	0.0211	CbGbCtD
Nelfinavir—CYP3A7—Docetaxel—pancreatic cancer	0.0172	0.0209	CbGbCtD
Nelfinavir—CYP3A7-CYP3A51P—Docetaxel—pancreatic cancer	0.0172	0.0209	CbGbCtD
Nelfinavir—CYP3A7—Sunitinib—pancreatic cancer	0.0171	0.0208	CbGbCtD
Nelfinavir—CYP3A7-CYP3A51P—Sunitinib—pancreatic cancer	0.0171	0.0208	CbGbCtD
Nelfinavir—CYP1A2—Tamoxifen—pancreatic cancer	0.017	0.0207	CbGbCtD
Nelfinavir—CYP2C9—Tamoxifen—pancreatic cancer	0.0154	0.0187	CbGbCtD
Nelfinavir—ABCB1—Tamoxifen—pancreatic cancer	0.0149	0.0181	CbGbCtD
Nelfinavir—CYP1A2—Erlotinib—pancreatic cancer	0.0145	0.0176	CbGbCtD
Nelfinavir—CYP2D6—Tamoxifen—pancreatic cancer	0.014	0.0171	CbGbCtD
Nelfinavir—CYP3A5—Docetaxel—pancreatic cancer	0.0129	0.0157	CbGbCtD
Nelfinavir—ABCB1—Gemcitabine—pancreatic cancer	0.0128	0.0156	CbGbCtD
Nelfinavir—CYP3A5—Sunitinib—pancreatic cancer	0.0128	0.0156	CbGbCtD
Nelfinavir—ABCB1—Erlotinib—pancreatic cancer	0.0127	0.0154	CbGbCtD
Nelfinavir—CYP1A2—Fluorouracil—pancreatic cancer	0.0126	0.0153	CbGbCtD
Nelfinavir—CYP2B6—Doxorubicin—pancreatic cancer	0.0122	0.0148	CbGbCtD
Nelfinavir—CYP2D6—Erlotinib—pancreatic cancer	0.0119	0.0145	CbGbCtD
Nelfinavir—ABCB1—Irinotecan—pancreatic cancer	0.0114	0.0139	CbGbCtD
Nelfinavir—CYP2C9—Fluorouracil—pancreatic cancer	0.0113	0.0138	CbGbCtD
Nelfinavir—CYP3A4—Tamoxifen—pancreatic cancer	0.00893	0.0109	CbGbCtD
Nelfinavir—ABCB1—Docetaxel—pancreatic cancer	0.00839	0.0102	CbGbCtD
Nelfinavir—ABCB1—Sunitinib—pancreatic cancer	0.00835	0.0101	CbGbCtD
Nelfinavir—CYP3A4—Erlotinib—pancreatic cancer	0.00759	0.00923	CbGbCtD
Nelfinavir—CYP3A4—Irinotecan—pancreatic cancer	0.00686	0.00834	CbGbCtD
Nelfinavir—ABCB1—Doxorubicin—pancreatic cancer	0.00625	0.0076	CbGbCtD
Nelfinavir—CYP2D6—Doxorubicin—pancreatic cancer	0.00589	0.00716	CbGbCtD
Nelfinavir—CYP3A4—Docetaxel—pancreatic cancer	0.00503	0.00611	CbGbCtD
Nelfinavir—CYP3A4—Sunitinib—pancreatic cancer	0.005	0.00608	CbGbCtD
Nelfinavir—CYP3A4—Doxorubicin—pancreatic cancer	0.00375	0.00455	CbGbCtD
Nelfinavir—Mitiglinide—PPARG—pancreatic cancer	0.0017	1	CrCbGaD
Nelfinavir—Immune system disorder—Docetaxel—pancreatic cancer	0.000216	0.00123	CcSEcCtD
Nelfinavir—Headache—Erlotinib—pancreatic cancer	0.000216	0.00123	CcSEcCtD
Nelfinavir—Gastrointestinal haemorrhage—Doxorubicin—pancreatic cancer	0.000216	0.00123	CcSEcCtD
Nelfinavir—Liver function test abnormal—Epirubicin—pancreatic cancer	0.000216	0.00123	CcSEcCtD
Nelfinavir—Paraesthesia—Gemcitabine—pancreatic cancer	0.000215	0.00123	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.000215	0.00122	CcSEcCtD
Nelfinavir—Asthenia—Sunitinib—pancreatic cancer	0.000214	0.00122	CcSEcCtD
Nelfinavir—Decreased appetite—Irinotecan—pancreatic cancer	0.000214	0.00122	CcSEcCtD
Nelfinavir—Dyspnoea—Gemcitabine—pancreatic cancer	0.000214	0.00122	CcSEcCtD
Nelfinavir—Abdominal pain upper—Epirubicin—pancreatic cancer	0.000213	0.00122	CcSEcCtD
Nelfinavir—Insomnia—Fluorouracil—pancreatic cancer	0.000213	0.00122	CcSEcCtD
Nelfinavir—Somnolence—Gemcitabine—pancreatic cancer	0.000213	0.00121	CcSEcCtD
Nelfinavir—Migraine—Doxorubicin—pancreatic cancer	0.000213	0.00121	CcSEcCtD
Nelfinavir—Affect lability—Doxorubicin—pancreatic cancer	0.000213	0.00121	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000213	0.00121	CcSEcCtD
Nelfinavir—Paraesthesia—Fluorouracil—pancreatic cancer	0.000212	0.00121	CcSEcCtD
Nelfinavir—Pruritus—Sunitinib—pancreatic cancer	0.000211	0.0012	CcSEcCtD
Nelfinavir—Pain—Irinotecan—pancreatic cancer	0.000211	0.0012	CcSEcCtD
Nelfinavir—Aspartate aminotransferase increased—Epirubicin—pancreatic cancer	0.00021	0.0012	CcSEcCtD
Nelfinavir—Dyspnoea—Fluorouracil—pancreatic cancer	0.00021	0.0012	CcSEcCtD
Nelfinavir—Somnolence—Fluorouracil—pancreatic cancer	0.00021	0.00119	CcSEcCtD
Nelfinavir—Erythema—Docetaxel—pancreatic cancer	0.000209	0.00119	CcSEcCtD
Nelfinavir—Malnutrition—Docetaxel—pancreatic cancer	0.000209	0.00119	CcSEcCtD
Nelfinavir—Decreased appetite—Gemcitabine—pancreatic cancer	0.000209	0.00119	CcSEcCtD
Nelfinavir—Dyspepsia—Fluorouracil—pancreatic cancer	0.000208	0.00118	CcSEcCtD
Nelfinavir—Nausea—Tamoxifen—pancreatic cancer	0.000207	0.00118	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000207	0.00118	CcSEcCtD
Nelfinavir—Alanine aminotransferase increased—Epirubicin—pancreatic cancer	0.000206	0.00117	CcSEcCtD
Nelfinavir—Muscular weakness—Epirubicin—pancreatic cancer	0.000206	0.00117	CcSEcCtD
Nelfinavir—Pain—Gemcitabine—pancreatic cancer	0.000205	0.00117	CcSEcCtD
Nelfinavir—Nausea—Erlotinib—pancreatic cancer	0.000205	0.00117	CcSEcCtD
Nelfinavir—Decreased appetite—Fluorouracil—pancreatic cancer	0.000205	0.00117	CcSEcCtD
Nelfinavir—Mood swings—Doxorubicin—pancreatic cancer	0.000205	0.00117	CcSEcCtD
Nelfinavir—Diarrhoea—Sunitinib—pancreatic cancer	0.000205	0.00117	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000204	0.00116	CcSEcCtD
Nelfinavir—Abdominal distension—Epirubicin—pancreatic cancer	0.000203	0.00116	CcSEcCtD
Nelfinavir—Feeling abnormal—Irinotecan—pancreatic cancer	0.000203	0.00116	CcSEcCtD
Nelfinavir—Back pain—Docetaxel—pancreatic cancer	0.000202	0.00115	CcSEcCtD
Nelfinavir—Pain—Fluorouracil—pancreatic cancer	0.000202	0.00115	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000201	0.00115	CcSEcCtD
Nelfinavir—Dehydration—Doxorubicin—pancreatic cancer	0.000201	0.00114	CcSEcCtD
Nelfinavir—Muscle spasms—Docetaxel—pancreatic cancer	0.000201	0.00114	CcSEcCtD
Nelfinavir—Liver function test abnormal—Doxorubicin—pancreatic cancer	0.0002	0.00114	CcSEcCtD
Nelfinavir—Pancreatitis—Epirubicin—pancreatic cancer	0.000198	0.00113	CcSEcCtD
Nelfinavir—Dizziness—Sunitinib—pancreatic cancer	0.000198	0.00113	CcSEcCtD
Nelfinavir—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000198	0.00113	CcSEcCtD
Nelfinavir—Abdominal pain upper—Doxorubicin—pancreatic cancer	0.000197	0.00112	CcSEcCtD
Nelfinavir—Body temperature increased—Irinotecan—pancreatic cancer	0.000195	0.00111	CcSEcCtD
Nelfinavir—Abdominal pain—Irinotecan—pancreatic cancer	0.000195	0.00111	CcSEcCtD
Nelfinavir—Aspartate aminotransferase increased—Doxorubicin—pancreatic cancer	0.000195	0.00111	CcSEcCtD
Nelfinavir—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000194	0.00111	CcSEcCtD
Nelfinavir—Anaemia—Docetaxel—pancreatic cancer	0.000193	0.0011	CcSEcCtD
Nelfinavir—Alanine aminotransferase increased—Doxorubicin—pancreatic cancer	0.000191	0.00109	CcSEcCtD
Nelfinavir—Muscular weakness—Doxorubicin—pancreatic cancer	0.000191	0.00109	CcSEcCtD
Nelfinavir—Vomiting—Sunitinib—pancreatic cancer	0.00019	0.00108	CcSEcCtD
Nelfinavir—Body temperature increased—Gemcitabine—pancreatic cancer	0.00019	0.00108	CcSEcCtD
Nelfinavir—Neutropenia—Epirubicin—pancreatic cancer	0.000189	0.00108	CcSEcCtD
Nelfinavir—Rash—Sunitinib—pancreatic cancer	0.000188	0.00107	CcSEcCtD
Nelfinavir—Dermatitis—Sunitinib—pancreatic cancer	0.000188	0.00107	CcSEcCtD
Nelfinavir—Abdominal distension—Doxorubicin—pancreatic cancer	0.000188	0.00107	CcSEcCtD
Nelfinavir—Urticaria—Fluorouracil—pancreatic cancer	0.000187	0.00107	CcSEcCtD
Nelfinavir—Headache—Sunitinib—pancreatic cancer	0.000187	0.00107	CcSEcCtD
Nelfinavir—Leukopenia—Docetaxel—pancreatic cancer	0.000187	0.00106	CcSEcCtD
Nelfinavir—Body temperature increased—Fluorouracil—pancreatic cancer	0.000186	0.00106	CcSEcCtD
Nelfinavir—Pancreatitis—Doxorubicin—pancreatic cancer	0.000183	0.00104	CcSEcCtD
Nelfinavir—Hyperglycaemia—Epirubicin—pancreatic cancer	0.000182	0.00104	CcSEcCtD
Nelfinavir—Hypersensitivity—Irinotecan—pancreatic cancer	0.000181	0.00103	CcSEcCtD
Nelfinavir—Pneumonia—Epirubicin—pancreatic cancer	0.000181	0.00103	CcSEcCtD
Nelfinavir—Convulsion—Docetaxel—pancreatic cancer	0.000181	0.00103	CcSEcCtD
Nelfinavir—Myalgia—Docetaxel—pancreatic cancer	0.000178	0.00101	CcSEcCtD
Nelfinavir—Arthralgia—Docetaxel—pancreatic cancer	0.000178	0.00101	CcSEcCtD
Nelfinavir—Nausea—Sunitinib—pancreatic cancer	0.000178	0.00101	CcSEcCtD
Nelfinavir—Asthenia—Irinotecan—pancreatic cancer	0.000177	0.00101	CcSEcCtD
Nelfinavir—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000176	0.001	CcSEcCtD
Nelfinavir—Jaundice—Epirubicin—pancreatic cancer	0.000175	0.000999	CcSEcCtD
Nelfinavir—Stomatitis—Epirubicin—pancreatic cancer	0.000175	0.000999	CcSEcCtD
Nelfinavir—Neutropenia—Doxorubicin—pancreatic cancer	0.000175	0.000995	CcSEcCtD
Nelfinavir—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000174	0.00099	CcSEcCtD
Nelfinavir—Sweating—Epirubicin—pancreatic cancer	0.000173	0.000983	CcSEcCtD
Nelfinavir—Asthenia—Gemcitabine—pancreatic cancer	0.000172	0.00098	CcSEcCtD
Nelfinavir—Hepatobiliary disease—Epirubicin—pancreatic cancer	0.00017	0.00097	CcSEcCtD
Nelfinavir—Oedema—Docetaxel—pancreatic cancer	0.00017	0.00097	CcSEcCtD
Nelfinavir—Epistaxis—Epirubicin—pancreatic cancer	0.00017	0.000967	CcSEcCtD
Nelfinavir—Pruritus—Gemcitabine—pancreatic cancer	0.00017	0.000967	CcSEcCtD
Nelfinavir—Sinusitis—Epirubicin—pancreatic cancer	0.000169	0.000962	CcSEcCtD
Nelfinavir—Hyperglycaemia—Doxorubicin—pancreatic cancer	0.000169	0.00096	CcSEcCtD
Nelfinavir—Diarrhoea—Irinotecan—pancreatic cancer	0.000168	0.00096	CcSEcCtD
Nelfinavir—Pneumonia—Doxorubicin—pancreatic cancer	0.000168	0.000954	CcSEcCtD
Nelfinavir—Pruritus—Fluorouracil—pancreatic cancer	0.000167	0.00095	CcSEcCtD
Nelfinavir—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000167	0.000949	CcSEcCtD
Nelfinavir—Skin disorder—Docetaxel—pancreatic cancer	0.000165	0.000942	CcSEcCtD
Nelfinavir—Diarrhoea—Gemcitabine—pancreatic cancer	0.000164	0.000935	CcSEcCtD
Nelfinavir—Dizziness—Irinotecan—pancreatic cancer	0.000163	0.000928	CcSEcCtD
Nelfinavir—Haemoglobin—Epirubicin—pancreatic cancer	0.000162	0.000925	CcSEcCtD
Nelfinavir—Stomatitis—Doxorubicin—pancreatic cancer	0.000162	0.000925	CcSEcCtD
Nelfinavir—Jaundice—Doxorubicin—pancreatic cancer	0.000162	0.000925	CcSEcCtD
Nelfinavir—Anorexia—Docetaxel—pancreatic cancer	0.000162	0.000924	CcSEcCtD
Nelfinavir—Rhinitis—Epirubicin—pancreatic cancer	0.000162	0.000923	CcSEcCtD
Nelfinavir—Haemorrhage—Epirubicin—pancreatic cancer	0.000162	0.000921	CcSEcCtD
Nelfinavir—Hepatitis—Epirubicin—pancreatic cancer	0.000162	0.000921	CcSEcCtD
Nelfinavir—Diarrhoea—Fluorouracil—pancreatic cancer	0.000161	0.000919	CcSEcCtD
Nelfinavir—Pharyngitis—Epirubicin—pancreatic cancer	0.00016	0.000914	CcSEcCtD
Nelfinavir—Sweating—Doxorubicin—pancreatic cancer	0.00016	0.00091	CcSEcCtD
Nelfinavir—Connective tissue disorder—Epirubicin—pancreatic cancer	0.000159	0.000905	CcSEcCtD
Nelfinavir—Hepatobiliary disease—Doxorubicin—pancreatic cancer	0.000158	0.000897	CcSEcCtD
Nelfinavir—Epistaxis—Doxorubicin—pancreatic cancer	0.000157	0.000895	CcSEcCtD
Nelfinavir—Vomiting—Irinotecan—pancreatic cancer	0.000157	0.000892	CcSEcCtD
Nelfinavir—Sinusitis—Doxorubicin—pancreatic cancer	0.000156	0.00089	CcSEcCtD
Nelfinavir—Dizziness—Fluorouracil—pancreatic cancer	0.000156	0.000888	CcSEcCtD
Nelfinavir—Rash—Irinotecan—pancreatic cancer	0.000155	0.000884	CcSEcCtD
Nelfinavir—Dermatitis—Irinotecan—pancreatic cancer	0.000155	0.000884	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000155	0.000883	CcSEcCtD
Nelfinavir—Headache—Irinotecan—pancreatic cancer	0.000154	0.000879	CcSEcCtD
Nelfinavir—Insomnia—Docetaxel—pancreatic cancer	0.000154	0.000877	CcSEcCtD
Nelfinavir—Paraesthesia—Docetaxel—pancreatic cancer	0.000153	0.000871	CcSEcCtD
Nelfinavir—Erythema multiforme—Epirubicin—pancreatic cancer	0.000153	0.00087	CcSEcCtD
Nelfinavir—Vomiting—Gemcitabine—pancreatic cancer	0.000153	0.000869	CcSEcCtD
Nelfinavir—Dyspnoea—Docetaxel—pancreatic cancer	0.000152	0.000864	CcSEcCtD
Nelfinavir—Somnolence—Docetaxel—pancreatic cancer	0.000151	0.000862	CcSEcCtD
Nelfinavir—Rash—Gemcitabine—pancreatic cancer	0.000151	0.000861	CcSEcCtD
Nelfinavir—Dermatitis—Gemcitabine—pancreatic cancer	0.000151	0.000861	CcSEcCtD
Nelfinavir—Eye disorder—Epirubicin—pancreatic cancer	0.000151	0.00086	CcSEcCtD
Nelfinavir—Haemoglobin—Doxorubicin—pancreatic cancer	0.00015	0.000856	CcSEcCtD
Nelfinavir—Headache—Gemcitabine—pancreatic cancer	0.00015	0.000856	CcSEcCtD
Nelfinavir—Vomiting—Fluorouracil—pancreatic cancer	0.00015	0.000854	CcSEcCtD
Nelfinavir—Rhinitis—Doxorubicin—pancreatic cancer	0.00015	0.000854	CcSEcCtD
Nelfinavir—Dyspepsia—Docetaxel—pancreatic cancer	0.00015	0.000853	CcSEcCtD
Nelfinavir—Haemorrhage—Doxorubicin—pancreatic cancer	0.00015	0.000852	CcSEcCtD
Nelfinavir—Hepatitis—Doxorubicin—pancreatic cancer	0.00015	0.000852	CcSEcCtD
Nelfinavir—Rash—Fluorouracil—pancreatic cancer	0.000149	0.000847	CcSEcCtD
Nelfinavir—Dermatitis—Fluorouracil—pancreatic cancer	0.000149	0.000846	CcSEcCtD
Nelfinavir—Pharyngitis—Doxorubicin—pancreatic cancer	0.000148	0.000845	CcSEcCtD
Nelfinavir—Decreased appetite—Docetaxel—pancreatic cancer	0.000148	0.000843	CcSEcCtD
Nelfinavir—Headache—Fluorouracil—pancreatic cancer	0.000148	0.000842	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000147	0.000837	CcSEcCtD
Nelfinavir—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.000147	0.000837	CcSEcCtD
Nelfinavir—Angiopathy—Epirubicin—pancreatic cancer	0.000147	0.000835	CcSEcCtD
Nelfinavir—Nausea—Irinotecan—pancreatic cancer	0.000146	0.000833	CcSEcCtD
Nelfinavir—Immune system disorder—Epirubicin—pancreatic cancer	0.000146	0.000831	CcSEcCtD
Nelfinavir—Pain—Docetaxel—pancreatic cancer	0.000146	0.000829	CcSEcCtD
Nelfinavir—Nausea—Gemcitabine—pancreatic cancer	0.000142	0.000812	CcSEcCtD
Nelfinavir—Erythema multiforme—Doxorubicin—pancreatic cancer	0.000141	0.000805	CcSEcCtD
Nelfinavir—Erythema—Epirubicin—pancreatic cancer	0.000141	0.000801	CcSEcCtD
Nelfinavir—Malnutrition—Epirubicin—pancreatic cancer	0.000141	0.000801	CcSEcCtD
Nelfinavir—Feeling abnormal—Docetaxel—pancreatic cancer	0.00014	0.000799	CcSEcCtD
Nelfinavir—Nausea—Fluorouracil—pancreatic cancer	0.00014	0.000798	CcSEcCtD
Nelfinavir—Eye disorder—Doxorubicin—pancreatic cancer	0.00014	0.000796	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000139	0.000793	CcSEcCtD
Nelfinavir—Flatulence—Epirubicin—pancreatic cancer	0.000139	0.00079	CcSEcCtD
Nelfinavir—Back pain—Epirubicin—pancreatic cancer	0.000136	0.000775	CcSEcCtD
Nelfinavir—Angiopathy—Doxorubicin—pancreatic cancer	0.000136	0.000773	CcSEcCtD
Nelfinavir—Muscle spasms—Epirubicin—pancreatic cancer	0.000135	0.00077	CcSEcCtD
Nelfinavir—Immune system disorder—Doxorubicin—pancreatic cancer	0.000135	0.000769	CcSEcCtD
Nelfinavir—Abdominal pain—Docetaxel—pancreatic cancer	0.000135	0.000766	CcSEcCtD
Nelfinavir—Body temperature increased—Docetaxel—pancreatic cancer	0.000135	0.000766	CcSEcCtD
Nelfinavir—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000131	0.000743	CcSEcCtD
Nelfinavir—Erythema—Doxorubicin—pancreatic cancer	0.00013	0.000741	CcSEcCtD
Nelfinavir—Malnutrition—Doxorubicin—pancreatic cancer	0.00013	0.000741	CcSEcCtD
Nelfinavir—Anaemia—Epirubicin—pancreatic cancer	0.00013	0.000741	CcSEcCtD
Nelfinavir—Agitation—Epirubicin—pancreatic cancer	0.000129	0.000736	CcSEcCtD
Nelfinavir—Flatulence—Doxorubicin—pancreatic cancer	0.000128	0.000731	CcSEcCtD
Nelfinavir—Malaise—Epirubicin—pancreatic cancer	0.000127	0.000723	CcSEcCtD
Nelfinavir—Leukopenia—Epirubicin—pancreatic cancer	0.000126	0.000717	CcSEcCtD
Nelfinavir—Back pain—Doxorubicin—pancreatic cancer	0.000126	0.000717	CcSEcCtD
Nelfinavir—Hypersensitivity—Docetaxel—pancreatic cancer	0.000125	0.000714	CcSEcCtD
Nelfinavir—Muscle spasms—Doxorubicin—pancreatic cancer	0.000125	0.000713	CcSEcCtD
Nelfinavir—Asthenia—Docetaxel—pancreatic cancer	0.000122	0.000696	CcSEcCtD
Nelfinavir—Convulsion—Epirubicin—pancreatic cancer	0.000122	0.000694	CcSEcCtD
Nelfinavir—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000121	0.000688	CcSEcCtD
Nelfinavir—Pruritus—Docetaxel—pancreatic cancer	0.00012	0.000686	CcSEcCtD
Nelfinavir—Anaemia—Doxorubicin—pancreatic cancer	0.00012	0.000685	CcSEcCtD
Nelfinavir—Arthralgia—Epirubicin—pancreatic cancer	0.00012	0.000682	CcSEcCtD
Nelfinavir—Myalgia—Epirubicin—pancreatic cancer	0.00012	0.000682	CcSEcCtD
Nelfinavir—Agitation—Doxorubicin—pancreatic cancer	0.00012	0.000681	CcSEcCtD
Nelfinavir—Anxiety—Epirubicin—pancreatic cancer	0.000119	0.00068	CcSEcCtD
Nelfinavir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000119	0.000678	CcSEcCtD
Nelfinavir—Discomfort—Epirubicin—pancreatic cancer	0.000118	0.000674	CcSEcCtD
Nelfinavir—Malaise—Doxorubicin—pancreatic cancer	0.000117	0.000669	CcSEcCtD
Nelfinavir—Leukopenia—Doxorubicin—pancreatic cancer	0.000117	0.000664	CcSEcCtD
Nelfinavir—Diarrhoea—Docetaxel—pancreatic cancer	0.000116	0.000663	CcSEcCtD
Nelfinavir—Oedema—Epirubicin—pancreatic cancer	0.000115	0.000654	CcSEcCtD
Nelfinavir—Convulsion—Doxorubicin—pancreatic cancer	0.000113	0.000642	CcSEcCtD
Nelfinavir—Dizziness—Docetaxel—pancreatic cancer	0.000113	0.000641	CcSEcCtD
Nelfinavir—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000112	0.00064	CcSEcCtD
Nelfinavir—Skin disorder—Epirubicin—pancreatic cancer	0.000112	0.000635	CcSEcCtD
Nelfinavir—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000111	0.000632	CcSEcCtD
Nelfinavir—Myalgia—Doxorubicin—pancreatic cancer	0.000111	0.000631	CcSEcCtD
Nelfinavir—Arthralgia—Doxorubicin—pancreatic cancer	0.000111	0.000631	CcSEcCtD
Nelfinavir—Anxiety—Doxorubicin—pancreatic cancer	0.00011	0.000629	CcSEcCtD
Nelfinavir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.00011	0.000627	CcSEcCtD
Nelfinavir—Discomfort—Doxorubicin—pancreatic cancer	0.000109	0.000624	CcSEcCtD
Nelfinavir—Anorexia—Epirubicin—pancreatic cancer	0.000109	0.000623	CcSEcCtD
Nelfinavir—Vomiting—Docetaxel—pancreatic cancer	0.000108	0.000616	CcSEcCtD
Nelfinavir—Rash—Docetaxel—pancreatic cancer	0.000107	0.000611	CcSEcCtD
Nelfinavir—Dermatitis—Docetaxel—pancreatic cancer	0.000107	0.000611	CcSEcCtD
Nelfinavir—Headache—Docetaxel—pancreatic cancer	0.000107	0.000607	CcSEcCtD
Nelfinavir—Oedema—Doxorubicin—pancreatic cancer	0.000106	0.000605	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000105	0.000596	CcSEcCtD
Nelfinavir—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000104	0.000592	CcSEcCtD
Nelfinavir—Insomnia—Epirubicin—pancreatic cancer	0.000104	0.000591	CcSEcCtD
Nelfinavir—Skin disorder—Doxorubicin—pancreatic cancer	0.000103	0.000588	CcSEcCtD
Nelfinavir—Paraesthesia—Epirubicin—pancreatic cancer	0.000103	0.000587	CcSEcCtD
Nelfinavir—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000103	0.000585	CcSEcCtD
Nelfinavir—Dyspnoea—Epirubicin—pancreatic cancer	0.000102	0.000583	CcSEcCtD
Nelfinavir—Somnolence—Epirubicin—pancreatic cancer	0.000102	0.000581	CcSEcCtD
Nelfinavir—Anorexia—Doxorubicin—pancreatic cancer	0.000101	0.000577	CcSEcCtD
Nelfinavir—Nausea—Docetaxel—pancreatic cancer	0.000101	0.000576	CcSEcCtD
Nelfinavir—Dyspepsia—Epirubicin—pancreatic cancer	0.000101	0.000576	CcSEcCtD
Nelfinavir—Decreased appetite—Epirubicin—pancreatic cancer	9.98e-05	0.000569	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Epirubicin—pancreatic cancer	9.91e-05	0.000565	CcSEcCtD
Nelfinavir—Pain—Epirubicin—pancreatic cancer	9.82e-05	0.000559	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	9.68e-05	0.000551	CcSEcCtD
Nelfinavir—Insomnia—Doxorubicin—pancreatic cancer	9.61e-05	0.000547	CcSEcCtD
Nelfinavir—Paraesthesia—Doxorubicin—pancreatic cancer	9.54e-05	0.000543	CcSEcCtD
Nelfinavir—Dyspnoea—Doxorubicin—pancreatic cancer	9.47e-05	0.000539	CcSEcCtD
Nelfinavir—Feeling abnormal—Epirubicin—pancreatic cancer	9.46e-05	0.000539	CcSEcCtD
Nelfinavir—Somnolence—Doxorubicin—pancreatic cancer	9.44e-05	0.000538	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Epirubicin—pancreatic cancer	9.39e-05	0.000535	CcSEcCtD
Nelfinavir—Dyspepsia—Doxorubicin—pancreatic cancer	9.35e-05	0.000533	CcSEcCtD
Nelfinavir—Decreased appetite—Doxorubicin—pancreatic cancer	9.23e-05	0.000526	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	9.17e-05	0.000522	CcSEcCtD
Nelfinavir—Urticaria—Epirubicin—pancreatic cancer	9.12e-05	0.00052	CcSEcCtD
Nelfinavir—Pain—Doxorubicin—pancreatic cancer	9.08e-05	0.000517	CcSEcCtD
Nelfinavir—Abdominal pain—Epirubicin—pancreatic cancer	9.08e-05	0.000517	CcSEcCtD
Nelfinavir—Body temperature increased—Epirubicin—pancreatic cancer	9.08e-05	0.000517	CcSEcCtD
Nelfinavir—Feeling abnormal—Doxorubicin—pancreatic cancer	8.75e-05	0.000499	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Doxorubicin—pancreatic cancer	8.69e-05	0.000495	CcSEcCtD
Nelfinavir—Hypersensitivity—Epirubicin—pancreatic cancer	8.46e-05	0.000482	CcSEcCtD
Nelfinavir—Urticaria—Doxorubicin—pancreatic cancer	8.44e-05	0.000481	CcSEcCtD
Nelfinavir—Abdominal pain—Doxorubicin—pancreatic cancer	8.4e-05	0.000478	CcSEcCtD
Nelfinavir—Body temperature increased—Doxorubicin—pancreatic cancer	8.4e-05	0.000478	CcSEcCtD
Nelfinavir—Asthenia—Epirubicin—pancreatic cancer	8.24e-05	0.000469	CcSEcCtD
Nelfinavir—Pruritus—Epirubicin—pancreatic cancer	8.12e-05	0.000463	CcSEcCtD
Nelfinavir—Diarrhoea—Epirubicin—pancreatic cancer	7.86e-05	0.000447	CcSEcCtD
Nelfinavir—Hypersensitivity—Doxorubicin—pancreatic cancer	7.83e-05	0.000446	CcSEcCtD
Nelfinavir—Asthenia—Doxorubicin—pancreatic cancer	7.62e-05	0.000434	CcSEcCtD
Nelfinavir—Dizziness—Epirubicin—pancreatic cancer	7.59e-05	0.000432	CcSEcCtD
Nelfinavir—Pruritus—Doxorubicin—pancreatic cancer	7.52e-05	0.000428	CcSEcCtD
Nelfinavir—Vomiting—Epirubicin—pancreatic cancer	7.3e-05	0.000416	CcSEcCtD
Nelfinavir—Diarrhoea—Doxorubicin—pancreatic cancer	7.27e-05	0.000414	CcSEcCtD
Nelfinavir—Rash—Epirubicin—pancreatic cancer	7.24e-05	0.000412	CcSEcCtD
Nelfinavir—Dermatitis—Epirubicin—pancreatic cancer	7.23e-05	0.000412	CcSEcCtD
Nelfinavir—Headache—Epirubicin—pancreatic cancer	7.19e-05	0.00041	CcSEcCtD
Nelfinavir—Dizziness—Doxorubicin—pancreatic cancer	7.02e-05	0.0004	CcSEcCtD
Nelfinavir—Nausea—Epirubicin—pancreatic cancer	6.82e-05	0.000388	CcSEcCtD
Nelfinavir—Vomiting—Doxorubicin—pancreatic cancer	6.75e-05	0.000385	CcSEcCtD
Nelfinavir—Rash—Doxorubicin—pancreatic cancer	6.7e-05	0.000382	CcSEcCtD
Nelfinavir—Dermatitis—Doxorubicin—pancreatic cancer	6.69e-05	0.000381	CcSEcCtD
Nelfinavir—Headache—Doxorubicin—pancreatic cancer	6.65e-05	0.000379	CcSEcCtD
Nelfinavir—Nausea—Doxorubicin—pancreatic cancer	6.31e-05	0.000359	CcSEcCtD
